Nail and mucocutaneous hyperpigmentation with azidothymidine therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2303586.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hyperpigmentation developed in six patients while they were receiving azidothymidine. All demonstrated hyperpigmentation of the nails; hyperpigmentation of the skin (two patients) and oral mucosa (two patients) also developed. The degree of nail pigmentation was related to the intrinsic skin color of the patient. Mucosal hyperpigmentation developed only in dark-skinned blacks. The pigmentation was due to increased melanin in the epidermis and dermis.
Medical subject headings
- Acquired Immunodeficiency Syndrome
- Nail Diseases
- Pigmentation Disorders
- Zidovudine